Development of effective immunization by DNA vaccine against iron-acquisition protein of periodontopathic bacteria
DNA疫苗开发针对牙周病细菌铁获取蛋白的有效免疫
基本信息
- 批准号:14370694
- 负责人:
- 金额:$ 8.38万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Lysine-specific cysteine proteinase (KGP) of Porphyromonas gingivalis, which is a prominent periodontopathic bacterium, is considered to play an important role in its pathogenesis, since it possesses protease activity as well as hemoglobin-binding activity. Previously, we reported that immunization of mice by injection of DNA vaccine against KGP into the muscle induced specific anti-KGP IgG antibodies in serum and that the DNA vaccine prevented inflammatory responses and prolonged the survival rate of the immunized mice against P gingivalis infection. The aim of this study was to investigate whether humoral immunity and cell-mediated immunity could be introduced when mice were immunized by injection of DNA vaccine into muscle or by oral administration of DNA vaccine-harboring avirulent bacterium that parasitizes in host cells; consequently to develop effective immunization. We constructed kgp-DNA vaccine (pCMV/kgp) for oral administration and transformed the plasmid into Salmonella typ … More himuriuin SL7207, which is an avirulent bacterium and was used as a vehicle for the DNA vaccine. Mice were immunized orally with the bacterium harboring the plasmid encoding kgp-DNA vaccine weekly for a total of four inoculations. Following the immunization, it was shown that specific anti-KGP IgG antibodies in serum were clearly induced by ELISA. Although induction of anti-KGP IgG antibodies in serum was observed when mice were immunized by injection of the DNA vaccine into muscle, the titers were lower than those when mice were orally immunized. Moreover, anti-KGP IgA antibodies in saliva were also introduced by immunization by oral administration of the DNA vaccine, while those were not observed when mice were immunized by intramuscular injection. We are now working on development of effective immunization methods and ion introduction of cell-mediated immunity and mucosal immunity. The present study indicates that immunization of kgp-DNA vaccine by oral administration may be a useful method to prevent periodontitis. Less
牙龈卟啉单胞菌是一种重要的牙周病细菌,其赖氨酸特异性半胱氨酸蛋白酶(KGP)被认为在其发病机制中发挥着重要作用,因为它具有蛋白酶活性以及血红蛋白结合活性。此前,我们报道了通过将针对KGP的DNA疫苗注射到肌肉中来免疫小鼠,在血清中诱导了特异性抗KGP IgG抗体,并且DNA疫苗预防了炎症反应并延长了免疫小鼠针对牙龈卟啉单胞菌感染的存活率。本研究的目的是探讨通过肌肉注射DNA疫苗或口服寄生在宿主细胞内的携带无毒力细菌的DNA疫苗来免疫小鼠,是否可以引入体液免疫和细胞介导的免疫。从而开展有效的免疫接种。我们构建了用于口服给药的 kgp-DNA 疫苗(pCMV/kgp),并将质粒转化为沙门氏菌型 Himuriuin SL7207,这是一种无毒细菌,用作 DNA 疫苗的载体。每周用携带编码kgp-DNA疫苗的质粒的细菌口服免疫小鼠,总共接种四次。免疫后,ELISA结果显示,血清中明显诱导出特异性抗KGP IgG抗体。虽然当通过将DNA疫苗注射到肌肉中来免疫小鼠时观察到血清中抗KGP IgG抗体的诱导,但是滴度低于小鼠口服免疫时的效价。此外,通过口服DNA疫苗免疫也引入了唾液中的抗KGP IgA抗体,而通过肌肉注射免疫小鼠时未观察到这些抗体。我们现在正在致力于开发有效的免疫方法以及细胞介导免疫和粘膜免疫的离子引入。本研究表明,口服kgp-DNA疫苗免疫可能是预防牙周炎的有效方法。较少的
项目成果
期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Masae Kuboniwa: "Quantitative detection of periodontal pathogens using real-time PCR with TaqMan probes"Oral Microbiology and Immunology. (in press). (2004)
Masae Kuboniwa:“使用实时 PCR 和 TaqMan 探针定量检测牙周病原体”口腔微生物学和免疫学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kazuhiko Maeda: "Glyceraldehyde-3-phosphate dehydrbgenase of Streptococcus oralis functions as a coadhesin for Porphyromonas gingivalis major fimbriae"Infection and Immunity. 72. 1341-1348 (2004)
Kazuhiko Maeda:“口腔链球菌的甘油醛-3-磷酸脱氢酶充当牙龈卟啉单胞菌大菌毛的粘附素”感染和免疫。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hideki Nagata: "Characterization of hemoglobin binding to Actinobacillus actinomycetemcomitans"Anaerobe. 8. 109-114 (2002)
Hideki Nagata:“血红蛋白与放线杆菌伴放线杆菌结合的特征”厌氧菌。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kosuke Kataoka: "Nasal Flt3 ligand cDNA elicits CD11c+CD8+ dendritic cells for enhanced mucosal immunity"Journal of Immunology. (in press). (2004)
Kosuke Kataoka:“鼻 Flt3 配体 cDNA 引发 CD11c CD8 树突状细胞以增强粘膜免疫”免疫学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nobuo Okahashi: "Porphyromonas gingivalis induces receptor activator of NF-κB ligand expression in osteoblasts through the activator protein 1 pathway"Infection and Immunity. 72. 1706-1714 (2004)
Nobuo Okahashi:“牙龈卟啉单胞菌通过激活蛋白 1 途径诱导成骨细胞中 NF-κB 配体受体激活剂的表达”《感染与免疫》72. 1706-1714 (2004)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHIZUKUISHI Satoshi其他文献
SHIZUKUISHI Satoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHIZUKUISHI Satoshi', 18)}}的其他基金
Molecular mechanism involved in the association of periodontal disease with pathology of metabolic syndrome
牙周病与代谢综合征病理关联的分子机制
- 批准号:
19209064 - 财政年份:2007
- 资助金额:
$ 8.38万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Elucidation of molecular mechanism of binding between periodontopathic bacteria and oral streptococci, and development of agents which inhibit forming of dental biofilm
阐明牙周病细菌与口腔链球菌结合的分子机制,开发抑制牙齿生物膜形成的药物
- 批准号:
17390564 - 财政年份:2005
- 资助金额:
$ 8.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of New Oral Health Practice Index Based on Lifestyle and Oral Health Age
基于生活方式和口腔健康年龄的新口腔健康实践指数的开发
- 批准号:
12557183 - 财政年份:2000
- 资助金额:
$ 8.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Biomolecular analysis on iron acquisition mechanism and pathogenicity of periodontopathic bacteria
牙周病细菌铁获取机制及致病性的生物分子分析
- 批准号:
11307050 - 财政年份:1999
- 资助金额:
$ 8.38万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Development of inhibitory peptide in oral bacterial coaggregation
口腔细菌共凝抑制肽的开发
- 批准号:
09044302 - 财政年份:1997
- 资助金额:
$ 8.38万 - 项目类别:
Grant-in-Aid for international Scientific Research
Development of inhibitory peptide in adherence of periodontopathic bacteria to dental plaqu
牙周病细菌粘附牙菌斑抑制肽的研制
- 批准号:
09557175 - 财政年份:1997
- 资助金额:
$ 8.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of structure and function of saliva protein receptor domains for periodontopathogen
牙周病原唾液蛋白受体结构域结构与功能分析
- 批准号:
08457568 - 财政年份:1996
- 资助金额:
$ 8.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of Smoking Cessation Training Program for Dental Team
牙科团队戒烟培训计划的制定
- 批准号:
07557285 - 财政年份:1995
- 资助金额:
$ 8.38万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
MECHANISMS OF IRON-A CQUISITION FROM HEMOGLOBIN IN PORPHYROMONAS GINGIVALIS
从牙龈卟啉单胞菌血红蛋白中获取铁的机制
- 批准号:
05454555 - 财政年份:1993
- 资助金额:
$ 8.38万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Role of Superoxide Dismutase in the Resistance of Periodontopathic Bacteria to Killing by Neutrophils
超氧化物歧化酶在牙周病细菌抵抗中性粒细胞杀灭中的作用
- 批准号:
02454469 - 财政年份:1990
- 资助金额:
$ 8.38万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
Targeting DKK1 with a DNA Vaccine to Prevent Development of Multiple Myeloma
用 DNA 疫苗靶向 DKK1 预防多发性骨髓瘤的发展
- 批准号:
10874135 - 财政年份:2023
- 资助金额:
$ 8.38万 - 项目类别:
Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccine
临床就绪的 MACH-1 基因枪,用于提供通用流感 DNA 疫苗
- 批准号:
10761364 - 财政年份:2023
- 资助金额:
$ 8.38万 - 项目类别:
A Single-dose DNA vaccine platform to safely induce protective immunity against Zika
单剂量 DNA 疫苗平台可安全诱导针对寨卡病毒的保护性免疫力
- 批准号:
10026208 - 财政年份:2022
- 资助金额:
$ 8.38万 - 项目类别:
Small Business Research Initiative
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
首个人类 Aβ DNA 疫苗的安全性/耐受性/免疫原性,AV-1959D 在早期 AD 受试者中的 1 期试验:基于 FDA 批准的 IND18953。
- 批准号:
10340654 - 财政年份:2022
- 资助金额:
$ 8.38万 - 项目类别:
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
首个人类 Aβ DNA 疫苗的安全性/耐受性/免疫原性,AV-1959D 在早期 AD 受试者中的 1 期试验:基于 FDA 批准的 IND18953。
- 批准号:
10571883 - 财政年份:2022
- 资助金额:
$ 8.38万 - 项目类别:
Integrin activator-adjuvanted DNA vaccine against Trypanosoma cruzi infection
整合素激活剂佐剂 DNA 疫苗对抗克氏锥虫感染
- 批准号:
10665082 - 财政年份:2022
- 资助金额:
$ 8.38万 - 项目类别:
Integrin activator-adjuvanted DNA vaccine against Trypanosoma cruzi infection
整合素激活剂佐剂 DNA 疫苗对抗克氏锥虫感染
- 批准号:
10544403 - 财政年份:2022
- 资助金额:
$ 8.38万 - 项目类别:
Development of an intradermal or inhaled DNA vaccine for COVID-19 and beyond
开发针对 COVID-19 及其他疾病的皮内或吸入 DNA 疫苗
- 批准号:
2599978 - 财政年份:2021
- 资助金额:
$ 8.38万 - 项目类别:
Studentship
A novel DNA vaccine that delivers long lasting immunity by stimulating high avidity CD8 T cells and strong neutralising antibodies
一种新型 DNA 疫苗,通过刺激高亲和力 CD8 T 细胞和强中和抗体来提供持久的免疫力
- 批准号:
73437 - 财政年份:2020
- 资助金额:
$ 8.38万 - 项目类别:
Collaborative R&D
Vaccination with self-launching RhCMV/SIV DNA vaccine vectors
使用自启动 RhCMV/SIV DNA 疫苗载体进行疫苗接种
- 批准号:
10037603 - 财政年份:2020
- 资助金额:
$ 8.38万 - 项目类别: